Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

48.17
-1.1800-2.39%
Post-market: 48.200.0300+0.06%19:56 EDT
Volume:5.85M
Turnover:284.22M
Market Cap:97.43B
PE:15.40
High:49.05
Open:48.93
Low:48.17
Close:49.35
52wk High:61.70
52wk Low:42.85
Shares:2.02B
Float Shares:1.94B
Volume Ratio:1.87
T/O Rate:0.30%
Dividend:1.80
Dividend Rate:3.75%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.16
PE(LYR):12.89

Loading ...

GlaxoSmithKline (GSK) Gets a Hold from RBC Capital

TIPRANKS
·
Sep 15

GSK Rises Monday, Outperforms Market

Dow Jones
·
Sep 15

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading

MT Newswires Live
·
Sep 14

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

Dow Jones
·
Sep 14

Movement Alert|GlaxoSmithKline PLC Rises 4.07% in Regular Trading, Lung Cancer Drug Jideytro Achieves 94% Response Rate in First-Line Trial

Market Focus
·
Sep 14

Sector Update: Healthcare Stocks Rise Premarket Monday

MT Newswires Live
·
Sep 14

【US Pre-Market】US Stock Futures Fall as AI Giants Call to Slow Model Development; AI Supply Chain Tumbles, Led by Memory and Optical Sectors

TradingKey
·
Sep 14

Movement Alert|GlaxoSmithKline PLC Rises 3.32% in Pre-Market Trading, Lung Cancer Drug Jideytro Achieves 94% Response Rate in First-Line Trial

Market Focus
·
Sep 14

J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Sep 14

GSK's Potential Small-Cell Lung Cancer Drug Meets Primary Endpoint in Late-Stage Trial

MT Newswires Live
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

GSK Says New Lung-Cancer Drug Shows Benefits at Earlier Stage of Treatment

Dow Jones
·
Sep 14

GSK licensor Hansoh announces ARTEMIS-008 phase III trial met primary endpoint

TIPRANKS
·
Sep 13

GSK Slides Thursday, Underperforms Market

Dow Jones
·
Sep 11

GSK announces Japan’s MHLW approved prefilled syringe presentation of Shingrix

TIPRANKS
·
Sep 10

GSK Gets Japan Approval for Prefilled Shingrix Syringe

MT Newswires Live
·
Sep 10

GSK Has Limited Margin for Error to Hit 2031 Target

Dow Jones
·
Sep 09

RBC Capital downgrades GlaxoSmithKline (GSK) to a Hold

TIPRANKS
·
Sep 09

Market Chatter: GSK to Raise $6.5 Billion From US Debt Sale to Fund Nuvalent Acquisition

MT Newswires Live
·
Sep 09

GSK to Raise $6.5 Billion From US Debt Sale to Fund Nuvalent Acquisition, Bloomberg Reports

MT Newswires Live
·
Sep 09